BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 17178982)

  • 1. An open-label adrenal suppression study of 0.1% fluocinonide cream in pediatric patients with atopic dermatitis.
    Schlessinger J; Miller B; Gilbert RD; Plott RT;
    Arch Dermatol; 2006 Dec; 142(12):1568-72. PubMed ID: 17178982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrocortisone butyrate 0.1% cream (proprietary lipid rich cream vehicle) does not significantly suppress hypothalamic-pituitary-adrenal axis and is effective in pediatric patients 3 months and older with extensive atopic dermatitis.
    Abramovits W; Oquendo M
    Skinmed; 2010; 8(3):150-4. PubMed ID: 21137620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of desonide hydrogel 0.05% on the hypothalamic-pituitary-adrenal axis in pediatric subjects with moderate to severe atopic dermatitis.
    Eichenfield LF; Basu S; Calvarese B; Trancik RJ
    Pediatr Dermatol; 2007; 24(3):289-95. PubMed ID: 17542883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical fluticasone propionate lotion does not cause HPA axis suppression.
    Hebert AA; Friedlander SF; Allen DB
    J Pediatr; 2006 Sep; 149(3):378-82. PubMed ID: 16939752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twice-daily versus once-daily applications of pimecrolimus cream 1% for the prevention of disease relapse in pediatric patients with atopic dermatitis.
    Ruer-Mulard M; Aberer W; Gunstone A; Kekki OM; López Estebaranz JL; Vertruyen A; Guettner A; Hultsch T
    Pediatr Dermatol; 2009; 26(5):551-8. PubMed ID: 19840309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of the HPA axis in pediatric patients with atopic dermatitis.
    Ishay A; Ziv M; Kerner M; Luboshitzky R
    Arch Dermatol; 2007 Nov; 143(11):1449-50. PubMed ID: 18025377
    [No Abstract]   [Full Text] [Related]  

  • 7. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
    Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K
    J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial.
    Reitamo S; Harper J; Bos JD; Cambazard F; Bruijnzeel-Koomen C; Valk P; Smith C; Moss C; Dobozy A; Palatsi R;
    Br J Dermatol; 2004 Mar; 150(3):554-62. PubMed ID: 15030341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative study of efficacy and effect on plasma cortisol levels of micronised desonide cream 0.1 p. 100 versus betamethasone dipropionate cream 0.05 p. 100 In the treatment of childhood atopic dermatitis].
    Lebrun-Vignes B; Legrain V; Amoric J; Taïeb A
    Ann Dermatol Venereol; 2000; 127(6-7):590-5. PubMed ID: 10930856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of desonide ointment, 0.05%, on the hypothalamic-pituitary-adrenal axis of children with atopic dermatitis.
    Lucky AW; Grote GD; Williams JL; Tuley MR; Czernielewski JM; Dolak TM; Herndon JH; Baker MD
    Cutis; 1997 Mar; 59(3):151-3. PubMed ID: 9071556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clobetasol propionate emulsion formulation foam 0.05%: review of phase II open-label and phase III randomized controlled trials in steroid-responsive dermatoses in adults and adolescents.
    Kimball AB; Gold MH; Zib B; Davis MW;
    J Am Acad Dermatol; 2008 Sep; 59(3):448-54, 454.e1. PubMed ID: 18539358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use.
    Paller AS; Eichenfield LF; Kirsner RS; Shull T; Jaracz E; Simpson EL;
    Pediatrics; 2008 Dec; 122(6):e1210-8. PubMed ID: 19015204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
    Kubota Y; Yoneda K; Nakai K; Katsuura J; Moriue T; Matsuoka Y; Miyamoto I; Ohya Y
    J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement in treatment adherence with a 3-day course of fluocinonide cream 0.1% for atopic dermatitis.
    Yentzer BA; Ade RA; Fountain JM; Clark AR; Taylor SL; Borgerding E; Feldman SR
    Cutis; 2010 Oct; 86(4):208-13. PubMed ID: 21140931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cushing's syndrome induced by misuse of moderate- to high-potency topical corticosteroids.
    Coureau B; Bussières JF; Tremblay S
    Ann Pharmacother; 2008 Dec; 42(12):1903-7. PubMed ID: 19017822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of atopic eczema with pimecrolimus cream 1% under daily practice conditions: results of a > 2000 patient study.
    Ring J; Abraham A; de Cuyper C; Kim K; Langeland T; Parra V; Pigatto P; Reunala T; Szczepanski R; Möhrenschlager M; Bräutigam M; Rossi AB; Meents-Kopecky E; Schneider D
    J Eur Acad Dermatol Venereol; 2008 Feb; 22(2):195-203. PubMed ID: 18211413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPA axis safety of fluticasone furoate nasal spray once daily in children with perennial allergic rhinitis.
    Tripathy I; Levy A; Ratner P; Clements D; Wu W; Philpot E
    Pediatr Allergy Immunol; 2009 May; 20(3):287-94. PubMed ID: 19175889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desonide foam 0.05%: safety in children as young as 3 months.
    Hebert AA;
    J Am Acad Dermatol; 2008 Aug; 59(2):334-40. PubMed ID: 18638631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of tacrolimus ointment in pediatric Patients with moderate to severe atopic dermatitis.
    Singalavanija S; Noppakun N; Limpongsanuruk W; Wisuthsarewong W; Aunhachoke K; Chunharas A; Wananukul S; Akaraphanth R
    J Med Assoc Thai; 2006 Nov; 89(11):1915-22. PubMed ID: 17205874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypothalamic-pituitary-adrenal function in children with atopic dermatitis treated with clobetasone butyrate and its clinical evaluation.
    Boner AL; Richelli C; De Stefano G; Valletta EA; Ferrari S; Mengoni M
    Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):118-20. PubMed ID: 2985514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.